Teva Pharmaceuticals Europe B.V.

TEVA PHARMACEUTICALS EUROPE B.V.

corporate_fareorganization

Web page: http://www.tevapharm.com

Country: Netherlands

Teva Pharmaceuticals Europe B.V.

- Funding / Projects
  (2)

2 Projects, page 1 of 1

BIO-DRIM (Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation)
Open Access Mandate for Publications assignment_turned_inProject2012 - 2018Partners:CELLOGIC, Institut klinické a experimentální mediciny, ICS, KLINIKUM DER UNIVERSITAET REGENSBURG, Charité - University Medicine Berlin +21 partners
CELLOGIC,
Institut klinické a experimentální mediciny,
ICS,
KLINIKUM DER UNIVERSITAET REGENSBURG,
Charité - University Medicine Berlin,
CHU,
ALTA SRLU,
MILENIA,
Astellas,
BRISTOL-MYERS SQUIBB GMBH & CO. KGAA,
UOXF,
Astellas,
Immunotech,
Teva Pharmaceuticals Europe B.V.,
KCL,
Amsterdam UMC,
MILENIA,
BRISTOL-MYERS SQUIBB GMBH & CO. KGAA,
Teva Pharmaceuticals Europe B.V.,
GID,
CELLOGIC,
UKE,
GID,
KLINIKUM DER UNIVERSITAET REGENSBURG,
ALTA SRLU,
Institut klinické a experimentální mediciny
Funder: European Commission Project Code: 305147
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
IPIE (Intelligent Assessment of Pharmaceutical in the Environment)
assignment_turned_inProject2015 - 2019Partners:SYNAPSE RESEARCH MANAGEMENT PARTNERS SL, University of Exeter, MERCK SHARP & DOHME CORP, AstraZeneca (Sweden), Eli Lilly and Company Limited +39 partners
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL,
University of Exeter,
MERCK SHARP & DOHME CORP,
AstraZeneca (Sweden),
Eli Lilly and Company Limited,
ECT OEKOTOXIKOLOGIE GMBH,
L Hoffman La Roche,
PFIZER,
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.,
BIF,
Janssen (Belgium),
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM,
NOVARTIS,
LL,
Eli Lilly and Company Limited,
LJMU,
MolNet,
BMS,
UBA,
ECT OEKOTOXIKOLOGIE GMBH,
Teva Pharmaceuticals Europe B.V.,
Teva Pharmaceuticals Europe B.V.,
BII GMBH,
UPF,
UBA,
Bayer AG,
Bayer AG,
BMS,
Roche (Switzerland),
UFZ,
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL,
MolNet,
STICHTING RADBOUD UNIVERSITEIT,
SARD,
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.,
MSD,
Janssen (Belgium),
NOVARTIS,
PFIZER,
LJMU,
LL,
Helmholtz Association of German Research Centres,
University of York,
AstraZeneca (Sweden)
Funder: European Commission Project Code: 115735
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Teva Pharmaceuticals Europe B.V.

Teva Pharmaceuticals Europe B.V.

2 Projects, page 1 of 1

BIO-DRIM (Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation)

IPIE (Intelligent Assessment of Pharmaceutical in the Environment)

Loading